Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar 2;7(3):e1000224.
doi: 10.1371/journal.pmed.1000224.

Where will the next generation of stroke treatments come from?

D W Howells  1 , G A Donnan
Affiliations

Where will the next generation of stroke treatments come from?

D W Howells et al. PLoS Med. .

Abstract

Remarkable progress has occurred over the last two decades in stroke interventions. Many have been developed on the basis of their efficacy in other disorders. This "inheritance" approach should continue, but two areas where completely novel therapeutic targets might emerge are the stimulation of neuroplasticity and unraveling the genetic code of stroke heterogeneity (Table 2). For the former, the next steps are to identify small-molecule, nontoxic compounds that most effectively enhance plasticity in animal models, and then subject them to clinical trial in humans. For the latter, more and larger-scale cooperative GWASs in carefully phenotyped stroke populations are required to better understand the polygenic nature of cerebrovascular disease. Then, the physiological relevance of genetic abnormalities can be determined in in vitro and in vivo systems before candidate compounds are developed.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Similar articles

See all similar articles

Cited by

  • Stroke: working toward a prioritized world agenda.
    Hachinski V, Donnan GA, Gorelick PB, Hacke W, Cramer SC, Kaste M, Fisher M, Brainin M, Buchan AM, Lo EH, Skolnick BE, Furie KL, Hankey GJ, Kivipelto M, Morris J, Rothwell PM, Sacco RL, Smith SC Jr, Wang Y, Bryer A, Ford GA, Iadecola C, Martins SC, Saver J, Skvortsova V, Bayley M, Bednar MM, Duncan P, Enney L, Finklestein S, Jones TA, Kalra L, Kleim J, Nitkin R, Teasell R, Weiller C, Desai B, Goldberg MP, Heiss WD, Saarelma O, Schwamm LH, Shinohara Y, Trivedi B, Wahlgren N, Wong LK, Hakim A, Norrving B, Prudhomme S, Bornstein NM, Davis SM, Goldstein LB, Leys D, Tuomilehto J; Stroke Synergium. Hachinski V, et al. Cerebrovasc Dis. 2010;30(2):127-47. doi: 10.1159/000315099. Epub 2010 May 24. Cerebrovasc Dis. 2010. PMID: 20516682 Free PMC article.
  • Stroke: working toward a prioritized world agenda.
    Hachinski V, Donnan GA, Gorelick PB, Hacke W, Cramer SC, Kaste M, Fisher M, Brainin M, Buchan AM, Lo EH, Skolnick BE, Furie KL, Hankey GJ, Kivipelto M, Morris J, Rothwell PM, Sacco RL, Smith SC Jr, Wang Y, Bryer A, Ford GA, Iadecola C, Martins SC, Saver J, Skvortsova V, Bayley M, Bednar MM, Duncan P, Enney L, Finklestein S, Jones TA, Kalra L, Kleim J, Nitkin R, Teasell R, Weiller C, Desai B, Goldberg MP, Heiss WD, Saarelma O, Schwamm LH, Shinohara Y, Trivedi B, Wahlgren N, Wong LK, Hakim A, Norrving B, Prudhomme S, Bornstein NM, Davis SM, Goldstein LB, Leys D, Tuomilehto J. Hachinski V, et al. Stroke. 2010 Jun;41(6):1084-99. doi: 10.1161/STROKEAHA.110.586156. Stroke. 2010. PMID: 20498453 Free PMC article. Review.
  • Bringing the hospital to the patient: first treatment of stroke patients at the emergency site.
    Walter S, Kostpopoulos P, Haass A, Helwig S, Keller I, Licina T, Schlechtriemen T, Roth C, Papanagiotou P, Zimmer A, Viera J, Körner H, Schmidt K, Romann MS, Alexandrou M, Yilmaz U, Grunwald I, Kubulus D, Lesmeister M, Ziegeler S, Pattar A, Golinski M, Liu Y, Volk T, Bertsch T, Reith W, Fassbender K. Walter S, et al. PLoS One. 2010 Oct 29;5(10):e13758. doi: 10.1371/journal.pone.0013758. PLoS One. 2010. PMID: 21060800 Free PMC article.
  • Discovery and Longitudinal Evaluation of Candidate Biomarkers for Ischaemic Stroke by Mass Spectrometry-Based Proteomics.
    Dagonnier M, Cooke IR, Faou P, Sidon TK, Dewey HM, Donnan GA, Howells DW. Dagonnier M, et al. Biomark Insights. 2017 Dec 20;12:1177271917749216. doi: 10.1177/1177271917749216. eCollection 2017. Biomark Insights. 2017. PMID: 29308009 Free PMC article.
  • Picroside II Exerts a Neuroprotective Effect by Inhibiting the Mitochondria Cytochrome C Signal Pathway Following Ischemia Reperfusion Injury in Rats.
    Zhang H, Zhai L, Wang T, Li S, Guo Y. Zhang H, et al. J Mol Neurosci. 2017 Feb;61(2):267-278. doi: 10.1007/s12031-016-0870-0. Epub 2017 Jan 4. J Mol Neurosci. 2017. Retraction in: J Mol Neurosci. 2025 Feb 13;75(1):20. doi: 10.1007/s12031-025-02319-6. PMID: 28054226 Retracted.
See all "Cited by" articles

References

    1. Leary MC, Saver JL. Annual incidence of first silent stroke in the United States: a preliminary estimate. Cerebrovasc Dis. 2003;16:280–285. - PubMed
    1. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008;371:1612–1623. - PubMed
    1. Mergenthaler P, Dirnagl U, Meisel A. Pathophysiology of stroke: lessons from animal models. Metab Brain Dis. 2004;19:151–167. - PubMed
    1. Donnan G, Baron J, Davis S, Sharp F. New York: Informa Health Care Inc; 2006. The Ischaemic Penumbra: history, current status and implications for therapy.
    1. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033–1041. - PubMed

Publication types